Oxford life sciences spin-out Orthox secures round from Isis Fund and Parkwalk.

Orthox, an Oxford spin-out developing regenerative tissue implants, has raised a seed round backed by Oxford University Isis Fund II and Parkwalk Funds.

The size of the round was not disclosed, but the cash from Oxford’s tech transfer office Isis Innovation and its fund manager Parkwalk will go towards exploiting and developing FibroFix, Orthox’s silk-based biomaterial platform. FibroFix can be used to repair injuries to cartilage and bone, and acts as both an immediate replacement for damaged cartilage as well as a long term repair platform.

 

This article is part of Global University Venturing’s free-to-access month. Subscriptions taken out this month will be 25% off.